bronchiolitis
BRONCHIOLITIS
Bronchiolitis is a clinical diagnosis preceding upper respiratory illness and/or rhinorrhea.
Signs of respiratory illness which may include wheezing, retractions, oxygen desaturation, color change, nasal flaring.
There is also presence of apnea especially in premature or low birthweight infants, signs of dehydration and exposure to persons with viral upper respiratory infections.
Symptoms are usually worst on the 3rd-5th day of illness and then improve gradually.

Bronchiolitis Drug Information

Drug Information

Indication: Treatment & relief of bronchospasm in patients w/ asthma, chronic bronchitis & emphysema.

Indication: Resp affections characterized by thick & viscous hypersecretions: Acute or chronic bronchitis & its ex...

Guadex
dextromethorphan hydrobromide + guaifenesin

Indication: Dry nonproductive cough.

Mendicof
dexchlorpheniramine maleate + dextromethorphan hyd...

Indication: Relief of unproductive cough & nasal congestion due to common cold or allergy.

Indication: Resp affections characterized by thick & viscous hypersecretions eg, acute & chronic bronchitis & ...

Indication: Secretolytic therapy in acute & chronic bronchopulmonary diseases associated w/ abnormal mucus secretion &...

Indication: Secretolytic therapy in acute & chronic bronchopulmonary diseases associated w/ abnormal mucus secretion &...

Paedicof
dexchlorpheniramine maleate + dextromethorphan hyd...

Indication: Relief of unproductive cough & nasal congestion due to common cold or allergy.

Indication: Relief of dry irritating cough associated w/ common cold, upper resp tract infections & allergic rhinitis....

2  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
3 days ago
Among patients with moderate-to-severe psoriasis, the use of biologics appears to lower the risk of being hospitalized for the novel coronavirus disease (COVID-19), a new study has found.